Clinical Study of Anti-CD19/BCMA Universal Chimeric Antigen Receptor T Cells (UCAR-T) in the Treatment of Refractory Idiopathic Membranous Nephropathy (IMN)
Clinical trial NCT07423572 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07423572
- Sponsor
- The First Affiliated Hospital of Zhejiang Chinese Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-28
- Primary completion
- 2028-02-28
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.